Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies

Get started →

Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

9801

1

SurgePays, Inc. SurgePays Reports 51.1% Revenue Decline, Net Loss, and Strategic Moves in Latest 10-Q Filing

Via official filing (AI summary) | 6 months ago | 0 comments

9802

1

Lifeloc Technologies, Inc Lifeloc Technologies Reports Decline in Financial Performance for Q3 and Nine Months Ended September 30, 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9803

1

Neumora Therapeutics, Inc. Neumora Therapeutics Reports Financial Results, Anticipates Additional Funding for Ongoing Operations and Product Development

Via official filing (AI summary) | 6 months ago | 0 comments

9804

1

United Health Products, Inc. United Health Products Reports Significant Financial Challenges, Net Loss in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

9805

1

INTELLIGENT PROTECTION MANAGEMENT CORP. Paltalk Reports Significant Financial Challenges, Net Loss of $1.5 Million in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9806

1

WEBTOON Entertainment Inc. WEBTOON Reports 9.5% Revenue Growth, Net Income Turnaround in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9807

1

Ready Capital Corp Ready Capital Corp Reports Significant Decline in Financial Performance for Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9808

1

Xtant Medical Holdings, Inc. Xtant Medical Holdings Reports 12% Revenue Growth, Widening Losses in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9809

1

abrdn Palladium ETF Trust abrdn Palladium ETF Trust Reports Increased Assets and Gains, Despite Decline in Net Asset Value

Via official filing (AI summary) | 6 months ago | 0 comments

9810

1

BioRestorative Therapies, Inc. BioRestorative Therapies Reports Improved Financials, Reduced Losses in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9811

1

Organogenesis Holdings Inc. Organogenesis Holdings Reports Mixed Q3 Results with Revenue Growth, Net Loss

Via official filing (AI summary) | 6 months ago | 0 comments

9812

1

Ispire Technology Inc. Ispire Technology Reports Decline in Revenue and Increased Net Losses in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9813

1

Aura Biosciences, Inc. Aura Biosciences Reports Financial Results, Advances Lead Candidate Bel-Sar in Phase 3 Trial

Via official filing (AI summary) | 6 months ago | 0 comments

9814

1

FIRST ADVANTAGE CORP First Advantage Reports Decline in Revenue and Profitability Amid Challenging Economic Conditions

Via official filing (AI summary) | 6 months ago | 0 comments

9815

1

Olema Pharmaceuticals, Inc. Olema Pharmaceuticals Reports Increased Loss and R&D Expenses in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

9816

1

Vroom, Inc. Vroom, Inc. Reports Significant Financial Challenges, Announces Restructuring Plan and Potential Chapter 11 Filing

Via official filing (AI summary) | 6 months ago | 0 comments

9817

1

Clearside Biomedical, Inc. Clearside Biomedical Reports Operating Losses, Strategic Developments, and Doubts Over Going Concern

Via official filing (AI summary) | 6 months ago | 0 comments

9818

1

Centurion Acquisition Corp. Centurion Acquisition Corp. Reports Net Income of $4.05M for Q3 2024, with $287.5M in Trust Account Funds

Via official filing (AI summary) | 6 months ago | 0 comments

9819

1

OCCIDENTAL PETROLEUM CORP /DE/ Occidental Petroleum Reports Mixed Q3 Results, Lower Revenues and Net Income

Via official filing (AI summary) | 6 months ago | 0 comments

9820

1

Paramount Gold Nevada Corp. Paramount Gold Nevada Reports Q3 2024 Financial Results, Net Loss Decreases 24% to $1.57M

Via official filing (AI summary) | 6 months ago | 0 comments

9821

1

Crinetics Pharmaceuticals, Inc. Crinetics Pharmaceuticals Reports Significant Financial Developments, Decline in Revenue, and Increased Expenses in Latest 10-Q Filing

Via official filing (AI summary) | 6 months ago | 0 comments

9822

1

MARA Holdings, Inc. Marathon Digital Holdings Reports 35% Revenue Growth, Operating Losses in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9823

1

Singular Genomics Systems, Inc. Singular Genomics Reports Continued Net Losses and Declining Revenues in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9824

1

Bolt Biotherapeutics, Inc. Bolt Biotherapeutics Reports Q3 2024 Financial Results, Net Loss Improves Amid Restructuring Efforts

Via official filing (AI summary) | 6 months ago | 0 comments

9825

1

FLUTTER ENTERTAINMENT PLC Flutter Entertainment Reports 27% Revenue Growth, Returns to Profitability in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments